Literature DB >> 18622337

Fetal and neonatal Graves disease: a case report and review of the literature.

Muhammad Aslam1, Musaddaq Inayat.   

Abstract

Fetal and neonatal thyrotoxicosis from maternal Graves disease is a very rare entity. Fetal symptoms result from the transplacental passage of thyroid-stimulating immunoglobulins, which persist in the neonate resulting in neonatal symptoms. We present a case of fetal and neonatal thyrotoxicosis from maternal Graves disease. Fetal symptoms were controlled with maternal administration of antithyroid drugs leading to fetal thyroid inhibition. We present this case with a brief review of the literature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622337     DOI: 10.1097/SMJ.0b013e31817dae27

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  A case of fetal hyperthyroidism treated with maternal administration of methimazole.

Authors:  Y Sato; M Murata; J Sasahara; S Hayashi; K Ishii; N Mitsuda
Journal:  J Perinatol       Date:  2014-12       Impact factor: 2.521

2.  Topical Iodine-Induced Thyrotoxicosis in a Newborn with a Giant Omphalocele.

Authors:  Sonali Malhotra; Shilpa Kumta; Alok Bhutada; Elka Jacobson-Dickman; Roja Motaghedi
Journal:  AJP Rep       Date:  2016-04

3.  Role of Maternal Thyroid-Stimulating Immunoglobulin in Graves' Disease for Predicting Perinatal Thyroid Dysfunction.

Authors:  Yiwen Cui; Asha Rijhsinghani
Journal:  AJP Rep       Date:  2019-11-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.